BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27474359)

  • 21. Quantification of cannabinoids in human hair using a modified derivatization procedure and liquid chromatography-tandem mass spectrometry.
    Al-Zahrani MA; Al-Asmari AI; Al-Zahrani FF; Torrance HJ; Watson DG
    Drug Test Anal; 2021 Jun; 13(6):1095-1107. PubMed ID: 33491296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simplified analysis of 11-hydroxy-delta-9-tetrahydrocannabinol and 11-carboxy-delta-9-tetrahydrocannabinol in human meconium: method development and validation.
    Tynon M; Porto M; Logan BK
    J Anal Toxicol; 2015; 39(1):35-40. PubMed ID: 25315472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First application of atmospheric-pressure chemical ionization gas chromatography tandem mass spectrometry to the determination of cannabinoids in serum.
    Gottardo R; Sorio D; Ballotari M; Tagliaro F
    J Chromatogr A; 2019 Apr; 1591():147-154. PubMed ID: 30679047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On-line SPE LC-MS/MS for the quantification of Δ9-tetrahydrocannabinol (THC) and its two major metabolites in human peripheral blood by liquid chromatography tandem mass spectrometry.
    König S; Aebi B; Lanz S; Gasser M; Weinmann W
    Anal Bioanal Chem; 2011 Apr; 400(1):9-16. PubMed ID: 21311875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel single-step GC-MS/MS method for cannabinoids and 11-OH-THC metabolite analysis in hair.
    Angeli I; Casati S; Ravelli A; Minoli M; Orioli M
    J Pharm Biomed Anal; 2018 Jun; 155():1-6. PubMed ID: 29602054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rapid and sensitive method for the identification of delta-9-tetrahydrocannabinol in oral fluid by liquid chromatography-tandem mass spectrometry.
    Molnar A; Lewis J; Doble P; Hansen G; Prolov T; Fu S
    Forensic Sci Int; 2012 Feb; 215(1-3):92-6. PubMed ID: 21367546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use?
    Kraemer M; Madea B; Hess C
    Drug Test Anal; 2019 Oct; 11(10):1498-1506. PubMed ID: 31407526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Method for Postmortem Tissue Quantification of Δ9-Tetrahydrocannabinol and Metabolites Using LC-MS-MS.
    Al-Asmari AI
    J Anal Toxicol; 2020 Oct; 44(7):718-733. PubMed ID: 32672807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of Cannabinoids in Breath Samples Using a Novel Derivatization LC-MS/MS Assay with Ultra-High Sensitivity.
    Luo YR; Yun C; Lynch KL
    J Anal Toxicol; 2019 Jun; 43(5):331-339. PubMed ID: 30951168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of an automated liquid-liquid extraction GC/MS method for the determination of THC, 11-OH-THC, and free THC-carboxylic acid (THC-COOH) from blood serum.
    Purschke K; Heinl S; Lerch O; Erdmann F; Veit F
    Anal Bioanal Chem; 2016 Jun; 408(16):4379-88. PubMed ID: 27116418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proof of cannabis administration by sensitive detection of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in hair using selective methylation and application of liquid chromatography- tandem and multistage mass spectrometry.
    Thieme D; Sachs H; Uhl M
    Drug Test Anal; 2014; 6(1-2):112-8. PubMed ID: 24424857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of cannabinoids in plasma using salting-out-assisted liquid-liquid extraction followed by LC-MS/MS analysis.
    da Silva CP; Dalpiaz LPP; Gerbase FE; Muller VV; Cezimbra da Silva A; Lizot LF; Hahn RZ; da Costa JL; Antunes MV; Linden R
    Biomed Chromatogr; 2020 Dec; 34(12):e4952. PubMed ID: 32706449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoids determination in oral fluid by SPME-GC/MS and UHPLC-MS/MS and its application on suspected drivers.
    Anzillotti L; Castrignanò E; Strano Rossi S; Chiarotti M
    Sci Justice; 2014 Dec; 54(6):421-6. PubMed ID: 25498928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Automated solid-phase extraction-liquid chromatography-tandem mass spectrometry analysis of 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human urine specimens: application to a high-throughput urine analysis laboratory.
    Robandt PV; Klette KL; Sibum M
    J Anal Toxicol; 2009 Oct; 33(8):456-60. PubMed ID: 19874652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of in utero cannabis exposure by umbilical cord analysis.
    Kim J; de Castro A; Lendoiro E; Cruz-Landeira A; López-Rivadulla M; Concheiro M
    Drug Test Anal; 2018 Apr; 10(4):636-643. PubMed ID: 28948698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoid Stability in Antemortem and Postmortem Blood.
    Meneses V; Mata D
    J Anal Toxicol; 2020 Mar; 44(2):126-132. PubMed ID: 31711171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validated method for the simultaneous determination of Delta9-THC and Delta9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography-mass spectrometry with electrospray ionization.
    Teixeira H; Verstraete A; Proença P; Corte-Real F; Monsanto P; Vieira DN
    Forensic Sci Int; 2007 Aug; 170(2-3):148-55. PubMed ID: 17614225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of measurement uncertainty for the quantification of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid and its glucuronide in urine using liquid chromatography-tandem mass spectrometry.
    Kim JY; Kwon W; Kim HS; Suh S; In MK
    J Anal Toxicol; 2014 Apr; 38(3):164-70. PubMed ID: 24519562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of an LC-MS/MS method for quantification of Δ9-tetrahydrocannabinolic acid A (THCA-A), THC, CBN and CBD in hair.
    Roth N; Moosmann B; Auwärter V
    J Mass Spectrom; 2013 Feb; 48(2):227-33. PubMed ID: 23378095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An automated and simultaneous solid-phase extraction of delta 9-tetrahydrocannabinol and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol from whole blood using the Zymark RapidTrace with confirmation and quantitation by GC-EI-MS.
    D'Asaro JA
    J Anal Toxicol; 2000; 24(4):289-95. PubMed ID: 10872577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.